Optimized Management of Cardio-Renal-Metabolic (CRM) Conditions in Patients With T2D
J Fam Pract. 2023 Jul;72(6 Suppl):S43-S48. doi: 10.12788/jfp.0622.ABSTRACTDescribe cardio-renal-metabolic (CRM) conditions and their impact on health and patient-centered outcomes. Recognize current gaps in screening, risk factor management, and utilization of guideline-directed therapies in patients with CRM conditions. Select appropriate guideline-directed therapies for patients with type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease based on current guidelines and clinical evidence. Recognize the importance of multidisciplinary care when managing patients with CRM conditions.PMID:37549412 | DOI:10.12788/jfp.0622
Source: The Journal of Family Practice - Category: Practice Management Authors: Jay H Shubrook Joshua J Neumiller Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Endocrinology | Family Practices | Heart | Heart Failure | Practice Management | Urology & Nephrology